$DXCM
DEXCOM INC Stock $dxcm

$dxcm Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000109355718000159 Filed on August 01, 2018

Income Statement

Concept	2018 Q2	2017 Q2
Revenue	$242.5M	$170.6M
YoY Change	42.15%	24.25%
Cost Of Revenue	$88.90M	$53.10M
YoY Change	67.42%	2.51%
Gross Profit	$153.6M	$117.5M
YoY Change	30.72%	37.43%
Gross Profit Margin	63.34%	68.87%
Selling, General & Admin	$111.3M	$85.80M
YoY Change	29.72%	23.81%
% of Gross Profit	72.46%	73.02%
Research & Development	$47.20M	$45.30M
YoY Change	4.19%	24.79%
% of Gross Profit	30.73%	38.55%
Depreciation & Amortization	$6.700M	$3.900M
YoY Change	71.79%	0.0%
% of Gross Profit	4.36%	3.32%
Operating Expenses	$158.5M	$131.1M
YoY Change	20.9%	24.15%
Operating Profit	-$4.900M	-$13.60M
YoY Change	-63.97%	-32.34%
Interest Expense	$4.800M	$3.100M
YoY Change	54.84%	3000.0%
% of Operating Profit
Other Income/Expense, Net	-$3.400M	$1.800M
YoY Change	-288.89%
Pretax Income	$29.60M	-$14.40M
YoY Change	-305.56%	-28.36%
Income Tax	-$600.0K	-$17.30M
% Of Pretax Income	-2.03%
Net Earnings	$30.20M	$2.900M
YoY Change	941.38%	-114.36%
Net Earnings / Revenue	12.45%	1.7%
Basic Earnings Per Share	$0.34	$0.03
Diluted Earnings Per Share	$0.34	$0.03
COMMON SHARES
Basic Shares Outstanding	88.20M shares	86.40M shares
Diluted Shares Outstanding	89.40M shares	87.40M shares

Balance Sheet

Concept	2018 Q2	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$551.0M	$496.6M
YoY Change	10.95%	329.58%
Cash & Equivalents	$300.2M	$395.9M
Short-Term Investments	$250.8M	$100.7M
Other Short-Term Assets	$21.70M	$15.70M
YoY Change	38.22%	80.46%
Inventory	$46.20M	$42.80M
Prepaid Expenses
Receivables	$162.0M	$101.7M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$836.0M	$656.8M
YoY Change	27.28%	172.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$156.8M	$125.0M
YoY Change	25.44%	62.34%
Goodwill	$11.90M	$11.90M
YoY Change	0.0%	0.85%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.800M	$1.900M
YoY Change	47.37%	58.33%
Total Long-Term Assets	$171.5M	$138.8M
YoY Change	23.56%	51.2%
TOTAL ASSETS
Total Short-Term Assets	$836.0M	$656.8M
Total Long-Term Assets	$171.5M	$138.8M
Total Assets	$1.008B	$795.6M
YoY Change	26.63%	139.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$59.90M	$16.80M
YoY Change	256.55%	-25.0%
Accrued Expenses	$104.1M	$86.80M
YoY Change	19.93%	70.87%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$170.8M	$105.1M
YoY Change	62.51%	42.22%
LONG-TERM LIABILITIES
Long-Term Debt	$342.3M	$327.2M
YoY Change	4.61%
Other Long-Term Liabilities	$19.60M	$16.30M
YoY Change	20.25%	30.4%
Total Long-Term Liabilities	$19.60M	$16.30M
YoY Change	20.25%	30.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$170.8M	$105.1M
Total Long-Term Liabilities	$19.60M	$16.30M
Total Liabilities	$525.4M	$441.9M
YoY Change	18.9%	411.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$665.8M	-$660.4M
YoY Change	0.82%	11.03%
Common Stock	$1.149B	$1.016B
YoY Change	13.14%	20.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$482.1M	$353.7M
YoY Change
Total Liabilities & Shareholders Equity	$1.008B	$795.6M
YoY Change	26.63%	139.06%

Cashflow Statement

Concept	2018 Q2	2017 Q2
OPERATING ACTIVITIES
Net Income	$30.20M	$2.900M
YoY Change	941.38%	-114.36%
Depreciation, Depletion And Amortization	$6.700M	$3.900M
YoY Change	71.79%	0.0%
Cash From Operating Activities	$41.40M	$14.30M
YoY Change	189.51%	-28.86%
INVESTING ACTIVITIES
Capital Expenditures	-$10.30M	-$12.00M
YoY Change	-14.17%	14.29%
Acquisitions
YoY Change
Other Investing Activities	-$149.6M	-$73.30M
YoY Change	104.09%	-8244.44%
Cash From Investing Activities	-$159.9M	-$85.30M
YoY Change	87.46%	788.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-800.0K	314.4M
YoY Change	-100.25%	-45014.29%
NET CHANGE
Cash From Operating Activities	41.40M	14.30M
Cash From Investing Activities	-159.9M	-85.30M
Cash From Financing Activities	-800.0K	314.4M
Net Change In Cash	-119.3M	243.4M
YoY Change	-149.01%	2383.67%
FREE CASH FLOW
Cash From Operating Activities	$41.40M	$14.30M
Capital Expenditures	-$10.30M	-$12.00M
Free Cash Flow	$51.70M	$26.30M
YoY Change	96.58%	-14.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5600000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3400000	USD
	us-gaap	Available For Sale Equity Securities Gross Unrealized Gain AvailableForSaleEquitySecuritiesGrossUnrealizedGain	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	4900000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	6300000	USD
	dei	Document Period End Date DocumentPeriodEndDate	2018-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001093557
CY2018Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	88355733	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	DEXCOM INC
	dei	Trading Symbol TradingSymbol	DXCM
CY2017Q4	dxcm	Accrued Tax Audit And Legal Fees AccruedTaxAuditAndLegalFees	7100000	USD
CY2018Q2	dxcm	Accrued Tax Audit And Legal Fees AccruedTaxAuditAndLegalFees	15400000	USD
CY2017Q4	dxcm	Debt Instrument Current Value Upon Conversion DebtInstrumentCurrentValueUponConversion	0	USD
CY2018Q2	dxcm	Debt Instrument Current Value Upon Conversion DebtInstrumentCurrentValueUponConversion	55400000	USD
	dxcm	Effective Income Tax Rate Reconciliation Tax Benefit For Refunds Of Foreign Withholding Tax EffectiveIncomeTaxRateReconciliationTaxBenefitForRefundsOfForeignWithholdingTax	1200000	USD
CY2018Q2	dxcm	Fair Value Assets Level3 Transfers Amount FairValueAssetsLevel3TransfersAmount	0	USD
CY2017Q4	dxcm	Financing Lease Obligation FinancingLeaseObligation	6700000	USD
CY2018Q2	dxcm	Financing Lease Obligation FinancingLeaseObligation	7300000	USD
CY2017Q4	dxcm	Pharmacy Rebates PharmacyRebates	13900000	USD
CY2018Q2	dxcm	Pharmacy Rebates PharmacyRebates	19900000	USD
	dxcm	Recorded Unconditional Purchase Obligation Due Within One Year Maximum Term RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm	P1Y
	dxcm	Revenue Recognition Sales Returns Coverage Period RevenueRecognitionSalesReturnsCoveragePeriod	P30D
CY2017Q2	dxcm	Standard Product Warranty Accrual Charges To Costs And Expenses StandardProductWarrantyAccrualChargesToCostsAndExpenses	3400000	USD
	dxcm	Standard Product Warranty Accrual Charges To Costs And Expenses StandardProductWarrantyAccrualChargesToCostsAndExpenses	8400000	USD
CY2018Q2	dxcm	Standard Product Warranty Accrual Charges To Costs And Expenses StandardProductWarrantyAccrualChargesToCostsAndExpenses	3400000	USD
	dxcm	Standard Product Warranty Accrual Charges To Costs And Expenses StandardProductWarrantyAccrualChargesToCostsAndExpenses	7900000	USD
CY2017Q4	dxcm	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Asset Provisional Income Tax Expense TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpense	105700000	USD
CY2017Q4	dxcm	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense	0	USD
CY2018Q2	dxcm	Working Capital WorkingCapital	665200000	USD
CY2017Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	87200000	USD
CY2018Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	117900000	USD
CY2017Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	46700000	USD
CY2018Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	59900000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	134300000	USD
CY2018Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	162000000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	54800000	USD
CY2018Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	65500000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2600000	USD
CY2018Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1300000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1093700000	USD
CY2018Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1149100000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2100000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7500000	USD
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7400000	shares
CY2018Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4400000	shares
CY2017Q4	us-gaap	Assets Assets	904100000	USD
CY2018Q2	us-gaap	Assets Assets	1007500000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	744700000	USD
CY2018Q2	us-gaap	Assets Current AssetsCurrent	836000000	USD
CY2018Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2018Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	200000	USD
CY2018Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	251000000	USD
CY2017Q2	us-gaap	Available For Sale Equity Securities Gross Unrealized Gain AvailableForSaleEquitySecuritiesGrossUnrealizedGain	0	USD
CY2018Q2	us-gaap	Available For Sale Equity Securities Gross Unrealized Gain AvailableForSaleEquitySecuritiesGrossUnrealizedGain	42700000	USD
	us-gaap	Available For Sale Equity Securities Gross Unrealized Gain AvailableForSaleEquitySecuritiesGrossUnrealizedGain	50100000	USD
CY2017Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	107100000	USD
CY2018Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	305900000	USD
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2018Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	50100000	USD
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	200000	USD
CY2018Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	200000	USD
CY2017Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	107300000	USD
CY2018Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	256000000	USD
CY2018Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	249800000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	250800000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	107100000	USD
CY2018Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	250800000	USD
CY2018Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	1000000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	395900000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	441500000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	300200000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	606100000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94500000	USD
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	395900000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	441500000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	300500000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	301400000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-141000000	USD
CY2017Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	344600000	USD
CY2018Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	173900000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87300000	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	88700000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87000000	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	88400000	shares
CY2017Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	100000	USD
CY2018Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	100000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2600000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-39400000	USD
CY2018Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	33800000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7300000	USD
CY2017Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	381300000	USD
CY2018Q2	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	465800000	USD
CY2017Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	327600000	USD
CY2018Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	335000000	USD
CY2017Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	53100000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	101300000	USD
CY2018Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	88900000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	154400000	USD
CY2017Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	400000000	USD
CY2018Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	400000000	USD
CY2017Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P6M
CY2017Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	64400000	USD
CY2018Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	57800000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-17100000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	8700000	USD
CY2018Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	8100000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3200000	USD
CY2018Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	6800000	USD
CY2018Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	2000000	USD
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	1900000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7600000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12700000	USD
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1200000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1800000	USD
CY2017Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	1.20
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.29
CY2018Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.02
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.07
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	48500000	USD
CY2018Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	46100000	USD
CY2018Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	172600000	USD
CY2018Q2	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2017Q4	us-gaap	Foreign Earnings Repatriated ForeignEarningsRepatriated	41200000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	12100000	USD
CY2018Q2	us-gaap	Goodwill Goodwill	11900000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	117500000	USD
	us-gaap	Gross Profit GrossProfit	211600000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	153600000	USD
	us-gaap	Gross Profit GrossProfit	272500000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14400000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-54700000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	29600000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-17300000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15900000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-600000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-400000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1800000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	32900000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-500000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	28100000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	500000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3600000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2100000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2800000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1000000	USD
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	1500000	USD
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	1300000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6200000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5000000	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	3100000	USD
	us-gaap	Interest Expense InterestExpense	3600000	USD
CY2018Q2	us-gaap	Interest Expense InterestExpense	4800000	USD
	us-gaap	Interest Expense InterestExpense	9600000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	17000000	USD
CY2018Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	14800000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	45200000	USD
CY2018Q2	us-gaap	Inventory Net InventoryNet	46200000	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	20000000	USD
CY2018Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	21700000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8200000	USD
CY2018Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9700000	USD
CY2017Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	500000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	700000	USD
CY2018Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	2200000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3700000	USD
CY2017Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2800000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5600000	USD
CY2018Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2900000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5700000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	484700000	USD
CY2018Q2	us-gaap	Liabilities Liabilities	525400000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	904100000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1007500000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	138900000	USD
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	170800000	USD
CY2018Q2	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	195600000	USD
CY2018Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2018Q2	us-gaap	Litigation Reserve LitigationReserve	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	394700000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-106700000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	30200000	USD
	us-gaap	Net Income Loss NetIncomeLoss	6000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-175300000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14600000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	32700000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	2900000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-38800000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	131100000	USD
	us-gaap	Operating Expenses OperatingExpenses	265600000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	158500000	USD
	us-gaap	Operating Expenses OperatingExpenses	308100000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-13600000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-54000000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4900000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-35600000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	52500000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	3700000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	11700000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	11500000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	11100000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	9400000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	5100000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10700000	USD
CY2018Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	15200000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1700000	USD
CY2018Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2800000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-300000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-600000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3600000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1300000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18200000	USD
CY2018Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	19600000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-6100000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-4700000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1800000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2200000	USD
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5600000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3000000	USD
CY2017Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	2800000	USD
CY2018Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	4200000	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1800000	USD
	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	-3600000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	91400000	USD
CY2018Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	224100000	USD
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	0	USD
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34900000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25600000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2018Q2	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16600000	USD
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21700000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	389000000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5700000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5200000	USD
CY2017Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	75000000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	75000000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	19600000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	75400000	USD
CY2017Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	5000000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	9900000	USD
CY2018Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	4800000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	9200000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	200400000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	222300000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	145600000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	156800000	USD
CY2018Q2	us-gaap	Recorded Unconditional Purchase Obligation Due Within One Year RecordedUnconditionalPurchaseObligationDueWithinOneYear	87200000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	75000000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45300000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	93400000	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47200000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	92000000	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2018Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	300000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-671800000	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-665800000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	242500000	USD
CY2018Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	111300000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	426900000	USD
CY2017Q2	us-gaap	Revenues Revenues	170600000	USD
	us-gaap	Revenues Revenues	312900000	USD
CY2018Q2	us-gaap	Revenues Revenues	242500000	USD
	us-gaap	Revenues Revenues	426900000	USD
CY2018Q2	us-gaap	Self Insurance Reserve SelfInsuranceReserve	2700000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	85800000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	172200000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	216100000	USD
CY2017Q2	us-gaap	Share Based Compensation ShareBasedCompensation	25300000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	55900000	USD
CY2018Q2	us-gaap	Share Based Compensation ShareBasedCompensation	25600000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	50200000	USD
CY2016Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	9800000	USD
CY2017Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	9900000	USD
CY2017Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8300000	USD
CY2017Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8800000	USD
CY2018Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	8900000	USD
CY2018Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	7500000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	419400000	USD
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	482100000	USD
CY2017Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8000000	USD
CY2018Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	7200000	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	50100000	USD
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	87400000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85800000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89400000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88800000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86400000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85800000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88200000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87700000	shares
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Organization and Business</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DexCom, Inc. is a medical device company focused on the design, development and commercialization of</font><font style="font-family:inherit;font-size:10pt;"> continuous glucose monitoring (“CGM”)</font><font style="font-family:inherit;font-size:10pt;"> systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. Unless the context requires otherwise, the terms “we,” “us,” “our,” the “company,” or “DexCom” refer to DexCom, Inc. and its subsidiaries.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with </font><font style="font-family:inherit;font-size:10pt;">U.S. GAAP</font><font style="font-family:inherit;font-size:10pt;"> requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates include excess or obsolete inventories, valuation of inventory, warranty accruals, convertible debt, employee bonus, clinical trial expenses, allowance for bad debt, refunds, rebates, including pharmacy rebates and self-funded insurance liabilities. </font></div></div>

Files In Submission

Name	View Source	Status
0001093557-18-000159-index-headers.html	Edgar Link	pending
0001093557-18-000159-index.html	Edgar Link	pending
0001093557-18-000159.txt	Edgar Link	pending
0001093557-18-000159-xbrl.zip	Edgar Link	pending
dxcm-20180630.xml	Edgar Link	completed
dxcm-20180630.xsd	Edgar Link	pending
dxcm-20180630_cal.xml	Edgar Link	unprocessable
dxcm-20180630_def.xml	Edgar Link	unprocessable
dxcm-20180630_lab.xml	Edgar Link	unprocessable
dxcm-20180630_pre.xml	Edgar Link	unprocessable
dxcm-63018x10q.htm	Edgar Link	pending
dxcm6302018exhibit3101.htm	Edgar Link	pending
dxcm6302018exhibit3102.htm	Edgar Link	pending
dxcm6302018exhibit3201.htm	Edgar Link	pending
dxcm6302018exhibit3202.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DXCM
DEXCOM INC Stock $dxcm

2018 Q2 Form 10-Q Financial Statement

#000109355718000159 Filed on August 01, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DXCM DEXCOM INC Stock $dxcm

2018 Q2 Form 10-Q Financial Statement

#000109355718000159 Filed on August 01, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DXCM
DEXCOM INC Stock $dxcm